Bitcoin
$54,454.66
+2784.04
Ethereum
$3,176.58
+95.01
Litecoin
$71.23
+0.97
DigitalCash
$31.60
+1.46
Monero
$130.70
+4.98
Nxt
$0.00
-0
Ethereum Classic
$27.71
+0.76
Dogecoin
$0.09
0

Apogee: Potential To Target Autoimmune Disorders With Less Frequent Dosing (NASDAQ:APGE)

0

anusorn nakdee/iStock via Getty Images

Apogee Therapeutics (NASDAQ:APGE) has been able to achieve the first milestone in the advancement of its drug candidate APG777, which is being developed to treat patients with 1st-line moderate-to-severe Atopic dermatitis [AD]. It dosed the first

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

You have not selected any currencies to display
WP2Social Auto Publish Powered By : XYZScripts.com